<DOC>
	<DOCNO>NCT01965431</DOCNO>
	<brief_summary>The objective study evaluate effect multiple dos BI 207127 combined faldaprevir cardiac safety parameter healthy subject</brief_summary>
	<brief_title>Thorough QT Study Evaluate Effects BI 207127 ( Deleobuvir ) Combined With Faldaprevir Cardiac Safety Parameters Healthy Subjects .</brief_title>
	<detailed_description />
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Inclusion criterion : Healthy male female subject Subjects must able understand comply study requirement Age =18 =55 year BMI range : =18.5 =29.9 kg/m2 Exclusion criterion : relevant deviation healthy condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>